Navigation Links
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Date:12/18/2007

NEW YORK, Dec. 18 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and Mylan Inc. (NYSE: MYL) announced today that the novel beta blocker Bystolic(TM) (nebivolol) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypertension. Bystolic is a once daily medication that can be used alone or in combination with other hypertension treatments. Hypertension affects approximately 72 million adults in the U.S. and 65 percent of patients diagnosed with hypertension have not reduced their blood pressure to an acceptable range (blood pressure <140/90 mmHg), underscoring the need for additional therapeutic options.

(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )

Beta blockers are one of the most widely used classes of drugs in the United States. In an extensive clinical trial program involving more than 2,000 patients, Bystolic demonstrated significant reductions in sitting diastolic and systolic blood pressure in a general hypertensive population, which included 26 percent Black, 54 percent male, 19 percent elderly and 8 percent diabetic patients. The studies also found that Bystolic was well tolerated, with a low incidence of traditional beta blocker side effects. Like other beta blockers, Bystolic decreases heart rate and myocardial contractility, and suppresses renin activity. Bystolic is a selective beta 1 blocker at doses less than or equal to 10 mg per day and has the
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2007 PR Newswire.
All rights reserved

10

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Novel Technology Breaks Through Cancer Pain
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
6. NIST team develops novel method for nanostructured polymer thin films
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
9. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
10. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
11. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Tucson, Ariz. (PRWEB) May 23, 2013 ... world’s first and only FDA, Health Canada and CE ... Glasgow Science Centre in Scotland, which boasts more than ... Total Artificial Heart powered by the Freedom® portable ... one of the most advanced exhibitions of its kind. ...
(Date:5/23/2013)... 2013 Bed bugs already cost Alton Housing ... still ongoing, a report from kmov.com suggested that the said ... bug treatment. Meanwhile, to be of help, My Cleaning Products ... bed bug exterminator service. , The report, which ... so far spent $35,000 for bed bug elimination, ...
(Date:5/23/2013)... Watlow®, an industry leader in ... recently introduced its new catalog, Watlow® Heating Solutions. ... designing and manufacturing industrial heaters, Watlow provides the ... diverse customer needs. , A description of the ... of the book. These options allow high demand ...
(Date:5/23/2013)... 23, 2013 Just released this month on ... and author Barbara Roche: “Commit to Confidence: 30 Strategies ... with helpful tips and quotes from the fields of psychology ... tangible exercises that readers can do on their own or ... their personal and professional goals. , “My book ...
Breaking Biology Technology:SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3Bed Bug Exterminator Service Could Cost AHA $250K, My Cleaning Products Gives Tips How to Save Apartments from Costly Bed Bug Treatment 2Watlow Introduces Its New Industrial Heater Catalog 2
... There is an old rhetorical saying, "If a tree ... it make a sound?" That same question could be posed ... medical community at large still dismisses Morgellons as some kind ... being ignored doesn,t make their tragedy any less real. One ...
... Associates, Inc. has announced its elite class of 2011 ... Summit and Top Improver awards for clinical achievement and ... Press Ganey, the health care industry,s ... 10,000 health care organizations worldwide to create and sustain ...
... CYPRESS, Calif., Nov. 15, 2011 Quest Diagnostics Incorporated ... of diagnostic testing, information and services, today announced that ... Simplexa Cytomegalovirus (CMV) molecular test kit on the 3M™ ... Europe. The test is designed to enable hospital labs ...
Cached Biology Technology:The Foremost Expert on Morgellons Disease Highlights the Gravity of This Illness 2Nation's Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey 2Nation's Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey 3Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe 2Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe 3
(Date:5/24/2013)... After studying noise in one French Quarter neighborhood of ... exceeded municipal ordinances, Annette Hurley, PhD, Assistant Professor of ... Eric Arriaga, a third-year LSUHSC doctor of audiology student, ... own hearing health. Their case study is published online ... Practice Management ., "An important part of an audiologist,s ...
(Date:5/23/2013)... popular fruit, can be made both better-tasting and longer-lasting ... , "Working with GM tomatoes that are different to ... compound, allows us to pinpoint exactly how to breed ... John Innes Centre. , The research could also lead ... life characteristics because even higher levels of the compounds ...
(Date:5/23/2013)... discovering the new mechanism by which estrogen suppresses lipid ... a potential new approach toward treating certain liver diseases. ... colleagues believe they are changing long-held views in the ... of the journal Science Signaling . , "The ... has been that only receptors located in the nucleus ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... WASHINGTON The U.S. Environmental Protection Agency (EPA) is ... is releasing a database, called ToxRefDB, which allows scientists ... of toxicity testing results on hundreds of chemicals. ToxRefDB ... "Tens of thousands of chemicals are in commerce ...
... Forget what you know about how diseases are diagnosednew research ... FASEB Journal ( http://www.fasebj.org ) details a noninvasive ground-breaking ... before symptoms can be seen using traditional methods. Even better, ... that they may be reversed before any permanent damage can ...
... Baltimore was hired by Carnegie,s Department of Embryology to wash ... inner city youth. Now as head technician and manager of ... from Johns Hopkins University under her belt, she has authored ... acknowledged for technical assistance on countless others. Genetics researchers in ...
Cached Biology News:US Environmental Protection Agency opens access to chemical information 2New tool helps scientists 'see' molecular signals of eye disease before symptoms arise 2From lab dishwasher to distinguished researcher 2From lab dishwasher to distinguished researcher 3
Human IL-17D Affinity Purified Polyclonal Ab...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
... Immunogen: Synthetic peptide derived from an ... mTOR (Mammalian target of rapamycin FRAP RAFT1 ... mTOR protein. On Western blots it ... Reactivity: Human (positive control: HEK293 cell ...
... to qualitatively detect EGFR ... paraffin-embedded (FFPE) tissue sections, ... cell preparations, using Chromogenic ... Fluorescent In Situ Hybridization ...
Biology Products: